ScripResearch is exploding is around the microbiome, the trillions of microbes living in and on the human body, as a means to address a range of diseases. Academics are conducting early research, VCs are b
ScripThe first of Microbiotica Ltd. ’s unique bacterial mixes will reach the clinic within the next two years, for a so-far undeclared indication, says company co-founder and CEO Mike Romanos. “We have
ScripA UK microbiome-focused biotech, Microbiotica Ltd ., has become the second company to be spun out of the UK-based genome sequencing research facility, Wellcome Trust Sanger Institute , with financ
ScripThe window into the human microbiome is now officially open, with publicly funded projects in the US and Europe divulging new secrets of the bugs in our guts and mouths, on our skin and on various oth